Effects of cancer treatments for the cardiovascular system: occurrence, etiology, diagnostics, and treatment
Abstract
Author(s): Kavina Ganapathy, Devanshu J. Patel, Sulabh Mahajan, Suhas R. Mule, Vikram Shete, Jagtej Singh
Chemotherapy, radiation, and surgery are all used in combination in modern cancer treatment to both extend the life and cure the disease. But a lot of these medications can lead to heart problems, myocardial infarctions, hypertension, thromboembolism, and arrhythmias, among other cardiovascular issues. This article analyzes the prevalence of cardiotoxicity caused by commonly used chemotherapy medications and discusses the etiology, diagnosis, treatment, and prevention of these cardiovascular adverse effects. Given that it might have a major impact on cancer patients' overall prognosis and survival, cardiotoxicity linked with anticancer therapy must be recognized. The aging cancer patient population and the advent of various novel cancer medicines will certainly make cardiotoxicity a substantial concern for future use by cardiologists and oncologists.
Share this article
Editors List
-
Prof. Elhadi Miskeen
Obstetrics and Gynaecology Faculty of Medicine, University of Bisha, Saudi Arabia
-
Ahmed Hussien Alshewered
University of Basrah College of Medicine, Iraq
-
Sudhakar Tummala
Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh
-
Alphonse Laya
Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis
-
Fava Maria Giovanna
Onkologia i Radioterapia peer review process verified at publons
Indexed In
- Directory of Open Access Journals
- Scimago
- SCOPUS
- EBSCO A-Z
- MIAR
- Euro Pub
- Google Scholar
- Medical Project Poland
- PUBMED
- Cancer Index
- Gdansk University of Technology, Ministry Points 20